Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 383

1.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution.

Tabrizian P, Shrager B, Jibara G, Yang MJ, Romanoff A, Hiotis S, Sarpel U, Labow DM.

J Gastrointest Surg. 2014 May;18(5):1024-31. doi: 10.1007/s11605-014-2477-5. Epub 2014 Feb 28.

PMID:
24577736
2.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience.

Iversen LH, Rasmussen PC, Hagemann-Madsen R, Laurberg S.

Colorectal Dis. 2013 Jul;15(7):e365-72. doi: 10.1111/codi.12185.

PMID:
23458368
3.

Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM.

Ann Surg Oncol. 2015 May;22(5):1716-21. doi: 10.1245/s10434-014-3985-y. Epub 2014 Aug 22.

PMID:
25145504
4.

Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.

Sardi A, Jimenez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V.

Eur J Surg Oncol. 2013 Nov;39(11):1207-13. doi: 10.1016/j.ejso.2013.08.017. Epub 2013 Sep 2.

PMID:
24007834
5.

[Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal and appendiceal origin].

Berger Y, Zbar AP, Lebedyev A, Levi Y, Nevler A, Aderka D, Golan T, Purim O, Brenner B, Natur M, Gutman M.

Harefuah. 2014 Jun;153(6):315-9, 368. Hebrew.

PMID:
25095601
6.

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colorectal cancer with peritoneal carcinomatosis: Clinical outcomes at 2 tertiary referral centers in Korea.

Park EJ, Baik SH, Hur H, Min BS, Kang J, Han YD, Cho MS, Lee KY, Kim NK.

Medicine (Baltimore). 2017 May;96(21):e6632. doi: 10.1097/MD.0000000000006632.

7.

Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.

Berger Y, Aycart S, Mandeli JP, Heskel M, Sarpel U, Labow DM.

Surg Oncol. 2015 Sep;24(3):264-9. doi: 10.1016/j.suronc.2015.06.013. Epub 2015 Jun 23.

PMID:
26143715
8.

Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.

Klaver YL, Chua TC, Verwaal VJ, de Hingh IH, Morris DL.

J Surg Oncol. 2013 May;107(6):585-90. doi: 10.1002/jso.23303. Epub 2012 Dec 27.

PMID:
23280508
9.

Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis.

Marcotte E, Dubé P, Drolet P, Mitchell A, Frenette S, Leblanc G, Leclerc YE, Sideris L.

World J Surg Oncol. 2014 Nov 7;12:332. doi: 10.1186/1477-7819-12-332.

10.

Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: a prospective study of 216 patients.

Passot G, Bakrin N, Roux AS, Vaudoyer D, Gilly FN, Glehen O, Cotte E.

Eur J Surg Oncol. 2014 May;40(5):529-35. doi: 10.1016/j.ejso.2013.11.019. Epub 2013 Dec 14.

PMID:
24370285
11.

Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly.

Tabrizian P, Jibara G, Shrager B, Franssen B, Yang MJ, Sarpel U, Hiotis S, Labow D.

Surg Oncol. 2013 Sep;22(3):184-9. doi: 10.1016/j.suronc.2013.06.001. Epub 2013 Jul 1. Review.

12.

Repeat Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis.

Wong JF, Tan GH, Wang W, Soo KC, Teo MC.

World J Surg. 2015 Jun;39(6):1578-83. doi: 10.1007/s00268-015-2986-8.

PMID:
25651962
13.

Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.

Lord AC, Shihab O, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ.

Eur J Surg Oncol. 2015 Mar;41(3):396-9. doi: 10.1016/j.ejso.2014.08.476. Epub 2014 Sep 2.

PMID:
25216980
14.

Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Jimenez W, Sardi A, Nieroda C, Sittig M, Milovanov V, Nunez M, Aydin N, Gushchin V.

Ann Surg Oncol. 2014 Dec;21(13):4218-25. doi: 10.1245/s10434-014-3869-1. Epub 2014 Jul 2.

PMID:
24986239
15.

Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: the experience of a tertiary Asian center.

Teo MC, Ching Tan GH, Lim C, Chia CS, Tham CK, Soo KC.

Asian J Surg. 2015 Apr;38(2):65-73. doi: 10.1016/j.asjsur.2014.05.001. Epub 2014 Jul 22.

16.

Role of CRS and HIPEC in appendiceal and colorectal malignancies: Indian experience.

Gupta N, Asif S, Gandhi J, Rajpurohit S, Singh S.

Indian J Gastroenterol. 2017 Mar;36(2):126-130. doi: 10.1007/s12664-017-0747-3. Epub 2017 Apr 10.

PMID:
28393331
17.
18.

Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.

Golse N, Bakrin N, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O, Cotte E.

J Surg Oncol. 2012 Aug 1;106(2):197-203. doi: 10.1002/jso.23062. Epub 2012 Feb 13.

PMID:
22331814
19.

Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.

Chua TC, Quinn LE, Zhao J, Morris DL.

J Surg Oncol. 2013 Aug;108(2):81-8. doi: 10.1002/jso.23356. Epub 2013 Jun 5.

PMID:
23737041
20.

Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.

Muñoz-Casares FC, Medina-Fernández FJ, Arjona-Sánchez Á, Casado-Adam Á, Sánchez-Hidalgo JM, Rubio MJ, Ortega-Salas R, Muñoz-Villanueva MC, Rufián-Peña S, Briceño FJ.

Eur J Surg Oncol. 2016 Feb;42(2):224-33. doi: 10.1016/j.ejso.2015.11.006. Epub 2015 Nov 25.

PMID:
26673283

Supplemental Content

Support Center